Top Suppliers:I want be here


  • DC Chemicals Limited
  • China
  • Product Name: GPR39-C3
  • Price: $200.0/10mg $350.0/25mg $800.0/100mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1621175-65-2

1621175-65-2 structure
1621175-65-2 structure
  • Name: TC-G 1008
  • Chemical Name: N-[3-Chloro-4-({[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino}methyl)phenyl]methanesulfonamide
  • CAS Number: 1621175-65-2
  • Molecular Formula: C18H19ClN6O2S
  • Molecular Weight: 418.901
  • Catalog: Signaling Pathways GPCR/G Protein GHSR
  • Create Date: 2018-01-28 20:09:01
  • Modify Date: 2024-01-12 01:07:48
  • TC-G-1008 (GPR39-C3) is a potent and orally available GPR39 agonist with EC50 values of 0.4 and 0.8 nM for rat and human receptors respectively.

Name N-[3-Chloro-4-({[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino}methyl)phenyl]methanesulfonamide
Synonyms Methanesulfonamide, N-[3-chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]-
N-[3-Chloro-4-({[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino}methyl)phenyl]methanesulfonamide
GPR39-C3
TC-G-1008
Description TC-G-1008 (GPR39-C3) is a potent and orally available GPR39 agonist with EC50 values of 0.4 and 0.8 nM for rat and human receptors respectively.
Related Catalog
Target

IC50: 0.4 nM (GPR39), 0.8 nM (GPR39)[1]

In Vitro TC-G-1008 shows selectivity over a panel of kinases (IC50s>10 μM) and does not exhibit relevant binding affinity for the related ghrelin and neurotensin-1 receptors (IC50s>30 μM)[1]. In HEK293-GPR39 cells, GPR39-C3, which is a positive allosteric modulator, activates cAMP production (downstream of Gs), IP1 accumulation (downstream of Gq), SRF-RE-dependent transcription (downstream of G12/13), and β-arrestin recruitment. GPR39-C3 induces dose- and time-dependent loss of response in cAMP production by second challenge of the compound[2].
In Vivo Rat and mouse plasma protein binding for TC-G-1008 is measured as 99.3% and 99.1%, respectively. TC-G-1008 is orally bioavailable in mice and robustly induces acute GLP-1 levels. Upon single oral doses of 10, 30, and 100 mg/kg of aqueous suspensions in 0.5% methylcellulose/0.1% Tween 80, TC-G-1008 achieves, between 1 and 1.5 h, maximal exposures of 1.4, 6.1, and 25.3 μM, respectively[1].
Kinase Assay HEK293-GPR39 cells are plated and cultured in poly-d-lysine-coated, white, 384-well plates (4000 cells/well) in the growth medium overnight at 37°C in the presence of 5% CO2. For pretreatment of the cells with GPR39 ligands (TC-G-1008) or vehicle control (DMSO), the culture medium is removed and the cells are stimulated with GPR39 ligands in assay buffer for the indicated time at 37°C. Then, the compound solution is removed and washed twice with PBS containing 0.1% BSA. For measurement of intracellular cAMP, the cells are stimulated with drugs in stimulation buffer for 30 min at 37°C. The intracellular cAMP level is determined by using HTRF cAMP dynamic 2 kit[2].
Animal Admin Mice: Mice are given single oral doses of 10, 30, and 100 mg/kg of TC-G-1008[1].
References

[1]. Peukert S, et al. Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. ACS Med Chem Lett. 2014 Aug 4;5(10):1114-8.

[2]. Shimizu Y, et al. Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation. Biochem Pharmacol. 2017 Sep 15;140:105-114.

Density 1.5±0.1 g/cm3
Boiling Point 662.1±65.0 °C at 760 mmHg
Molecular Formula C18H19ClN6O2S
Molecular Weight 418.901
Flash Point 354.2±34.3 °C
Exact Mass 418.097870
LogP 1.14
Vapour Pressure 0.0±2.0 mmHg at 25°C
Index of Refraction 1.678
Storage condition 2-8℃